Evidence map›Paper›PMID 18662686›Full record

ArticleExperimental cell research2008

Chromatin context dominates estrogen regulation of pS2 gene expression.

Akua K Oduro, Michael K Fritsch, Fern E Murdoch

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Akua K OduroDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, MSC 5250, 1300 University Avenue, Madison, WI 53706, USA.
Michael K Fritsch
Fern E Murdoch
University of Wisconsin–Madison · US

Funding

Hormonal Control of Histone Modifications in ES CellsR01DK064243 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI FRITSCH, MICHAEL K · 2003 to 2007
$1.4M
NIDDK NIH HHS DK64243NIDDK NIH HHS R01 DK064243
6 · The paper itself

Abstract

Chromatin structure and transcription factor activity collaborate to set the transcription level of a gene. Our understanding of the relative contributions of each of these factors at a specific gene is limited. We studied the effects of an altered chromatin environment on the activity of the estrogen-responsive pS2 promoter. We created stable cell lines with the pS2 promoter situated in an alternative chromatin site in addition to it being in its native site. Both promoters were estrogen-responsive for estrogen receptor alpha (ERalpha) recruitment, but transcription was inducible only at the native site. At the recombinant site, transcription was high and constitutive. Higher histone H3 and H4 acetylation (acH3 and acH4), as well as trimethylated lysine 4 on histone H3 levels, was observed at the recombinant site compared to the native site in vehicle treated cells. Inhibition of histone deacetylases (HDACs) resulted in increased acH4, but only modest increases in acH3, ERalpha binding and basal transcription at the native pS2 site. Inhibiting HDACs had no effect on transcription from the recombinant site. These data suggest that highly active chromatin is not only permissive for transcription, but can override the requirement for the transcription factor at an inducible promoter.

Indexed as

AcetylationAnimalsCell LineChromatinEstrogen Receptor alphaEstrogensGene Expression RegulationHistonesHumansLysinePromoter Regions, GeneticRecombination, GeneticTranscription, GeneticTrefoil Factor-1Tumor Suppressor ProteinsChromatinEstrogen Receptor alphaEstrogensHistonesLysineTFF1 protein, humanTrefoil Factor-1Tumor Suppressor Proteins

Identifiers

PMID18662686
PMCPMC2646615
OpenAlexW2091843959

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.